Efficacy and Safety of Sovleplenib (HMPL-523) in Adult Patients with Chronic Primary Immune Thrombocytopenia in China (ESLIM-01): a Randomised, Double-Blind, Placebo-Controlled, Phase 3 StudyYu Hu,Xiaofan Liu,Hu Zhou,Shujie Wang,Ruibin Huang,Yi Wang,Xin Du,Jing Sun,Zeping Zhou,Zhenyu Yan,Wenming Chen,Wei Wang,Qingchi Liu,Qingshu Zeng,Yuping Gong,Jie Yin,Xuliang Shen,Baodong Ye, Yun Chen,Yajing Xu,Huiping Sun,Yunfeng Cheng,Zhuogang Liu,Chunling Wang, Guolin Yuan,Xiaohui Zhang,Xin Li,Peng Cheng,Xinhong Guo,Zhongxing Jiang,Feng'e Yang,Linhua Yang,Chengwei Luo,Taiwu Xiao, Sisi Fu,Hongyan Yin, Xiaojun Guo, Qian Xu,Songhua Fan,Michael M. Shi,Weiguo Su,Heng Mei,Renchi YangLANCET HAEMATOLOGY（2024）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
